A UK survey found patients and their relatives were overwhelmingly in favour of using artificial intelligence (AI) in diagnostic testing of inherited retinal diseases (IRDs) to accelerate genetic diag
Researchers in the US and Brazil have found that a cheap oral inflammasome inhibitor, commonly prescribed for patients with HIV, significantly improved vision in patients with centre-involved diabetic
US genetic med-tech company Krystal Biotech announced it had dosed its first patient in the IOLITE Phase 3 Study of KB803, a re-dosable eye drop gene therapy designed to treat and prevent corneal abra
US researchers found cannabis use moderately lowered the risk of proliferative vitreoretinopathy (PVR) development in patients who underwent retinal detachment (RD) repair.
A team of international researchers found artificially increasing levels of apolipoprotein M (ApoM), a natural protein involved in cholesterol metabolism, improved retinal pigment epithelium (RPE) function in mice with age-related macular degeneration (AMD).
Returning to the largest agricultural event in the Southern Hemisphere, Macular Degeneration New Zealand (MDNZ) delivered 345 OCT scans and had lots of conversations about the importance of eye-health checks at Fieldays in Mystery Creek, Hamilton.
Bringing together three influential leaders from the eye health sector, Specsavers has invited Chrissie Cowan, co-chair of Eye Health Aotearoa and CEO of Kāpō Māori Aotearoa; Carly Iles, CEO of Vision
A La Trobe University study investigating the rate or effect of bullying in smaller allied health professions found bullying and incivility are common and pose challenges for orthoptic students during placements.
In the week leading up to ODMA’s 2025 fair, Marchon threw open its doors for its first ever ‘First View 2025’, giving customers the opportunity to see its full October 2025 eyewear release.
Sharing new clinical evidence from three clinical studies, Hoya Vision Care said wearing Miyosmart spectacle lenses continuously and for the long-term may improve myopia management outcomes.
Following the acquisition of the Menrad brand and license agreements, Design Eyewear Group has appointed VMD as the exclusive distributor of Jaguar Eyewear in New Zealand and Australia.
Zeiss Vision Care is making the dream of a complete tech transformation a reality for one lucky independent eyecare practice with a chance to win AU$100,000 excluding GST (approx. NZ$107,912) worth of Zeiss equipment.
